Site-specific antibody-drug conjugates with variable drug-to-antibody-ratios for AML therapy.
Dai Z, Zhang XN, Cheng Q, Fei F, Hou T, Li J, Abdolvahabi A, Watanabe J, Pei H, Smbatyan G, Xie J, Lenz HJ, Louie SG, Zhang Y.
Dai Z, et al. Among authors: watanabe j.
J Control Release. 2021 Aug 10;336:433-442. doi: 10.1016/j.jconrel.2021.06.041. Epub 2021 Jun 29.
J Control Release. 2021.
PMID: 34197861
Free PMC article.